These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 34564882

  • 21. Diffuse large B-cell lymphoma with central nervous system relapse: prognosis and risk factors according to retrospective analysis from a single-center experience.
    Shimazu Y, Notohara K, Ueda Y.
    Int J Hematol; 2009 Jun; 89(5):577-83. PubMed ID: 19353238
    [Abstract] [Full Text] [Related]

  • 22. Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab.
    Tai WM, Chung J, Tang PL, Koo YX, Hou X, Tay KW, Quek R, Tao M, Lim ST.
    Ann Hematol; 2011 Jul; 90(7):809-18. PubMed ID: 21229246
    [Abstract] [Full Text] [Related]

  • 23. [CNS involvement and the feasibility of intratecal chemotherapy administration in patients with a nodal form of diffuse large B-cell lymphoma not otherwise specified. Data of prospective study].
    Magomedova AU, Misyurina AE, Mangasarova JK, Gorenkova LG, Margolin OV, Fastova EA, Kravchenko SK.
    Ter Arkh; 2019 Jul 15; 91(7):35-40. PubMed ID: 32598734
    [Abstract] [Full Text] [Related]

  • 24. Clinical analysis of patients with primary and secondary extranodal natural killer/T-cell lymphoma of central nervous system.
    Li X, Yu H, Fu X, Zhang L, Li X, Li L, Wang X, Sun Z, Zhang X, Li Z, Wu J, Chang Y, Yan J, Zhou Z, Nan F, Wu X, Tian L, Zhang M.
    Hematol Oncol; 2023 Apr 15; 41(2):267-274. PubMed ID: 34061378
    [Abstract] [Full Text] [Related]

  • 25. [Treatment strategy for central nervous system involvement in intravascular large B-cell lymphoma].
    Shimada K.
    Brain Nerve; 2011 May 15; 63(5):467-72. PubMed ID: 21515926
    [Abstract] [Full Text] [Related]

  • 26. Central nervous system involvement in diffuse large B-cell lymphoma: an analysis of risks and prevention strategies in the post-rituximab era.
    Fletcher CD, Kahl BS.
    Leuk Lymphoma; 2014 Oct 15; 55(10):2228-40. PubMed ID: 24286262
    [Abstract] [Full Text] [Related]

  • 27. Secondary central nervous system involvement in 599 patients with diffuse large B-cell lymphoma: are there any changes in the rituximab era?
    Deng L, Song Y, Zhu J, Zheng W, Wang X, Xie Y, Lin N, Tu M, Ping L, Ying Z, Liu W, Zhang C.
    Int J Hematol; 2013 Dec 15; 98(6):664-71. PubMed ID: 24234713
    [Abstract] [Full Text] [Related]

  • 28. Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.
    Guirguis HR, Cheung MC, Mahrous M, Piliotis E, Berinstein N, Imrie KR, Zhang L, Buckstein R.
    Br J Haematol; 2012 Oct 15; 159(1):39-49. PubMed ID: 22849793
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era: a systematic review.
    Eyre TA, Djebbari F, Kirkwood AA, Collins GP.
    Haematologica; 2020 Jul 15; 105(7):1914-1924. PubMed ID: 31488560
    [Abstract] [Full Text] [Related]

  • 30. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
    Mao L, Wang X, Wang CY, Xia B, Ning QY, Yang HL, Yu Y, Zhang YZ.
    Zhonghua Yi Xue Za Zhi; 2019 Jun 25; 99(24):1853-1858. PubMed ID: 31269579
    [Abstract] [Full Text] [Related]

  • 31. The role of central nervous system (CNS) prophylaxis in preventing DLBCL patients from CNS relapse: A network meta-analysis.
    Lin Z, Chen X, Liu L, Zeng H, Li Z, Xu B.
    Crit Rev Oncol Hematol; 2022 Aug 25; 176():103756. PubMed ID: 35809794
    [Abstract] [Full Text] [Related]

  • 32. Central nervous system involvement in intravascular large B-cell lymphoma: a retrospective analysis of 109 patients.
    Shimada K, Murase T, Matsue K, Okamoto M, Ichikawa N, Tsukamoto N, Niitsu N, Miwa H, Asaoku H, Kosugi H, Kikuchi A, Matsumoto M, Saburi Y, Masaki Y, Yamamoto K, Yamaguchi M, Nakamura S, Naoe T, Kinoshita T, IVL Study Group in Japan.
    Cancer Sci; 2010 Jun 25; 101(6):1480-6. PubMed ID: 20412122
    [Abstract] [Full Text] [Related]

  • 33. [Clinical pathologic characteristics and treatment outcomes of 19 relapsed pediatric B-cell lymphoma].
    Huang S, Jin L, Yang J, Duan YL, Zhang M, Zhou CJ, Ma XL, Zhang YH.
    Zhonghua Er Ke Za Zhi; 2017 Oct 02; 55(10):748-753. PubMed ID: 29050112
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Extranodal site of diffuse large B-cell lymphoma and the risk of R-CHOP chemotherapy resistance and early relapse.
    Ting CY, Gan GG, Bee-Lan Ong D, Tan SY, Bee PC.
    Int J Clin Pract; 2020 Oct 02; 74(10):e13594. PubMed ID: 32583545
    [Abstract] [Full Text] [Related]

  • 36. [Clinical characteristics of 46 pediatric diffuse large B-cell lymphoma and treatment outcome].
    Huang S, Yang J, Jin L, Duan YL, Zhang M, Zhang NN, Li Q, Zhang N, Zhou CJ, Zhang YH.
    Zhonghua Er Ke Za Zhi; 2019 Oct 02; 57(10):774-779. PubMed ID: 31594064
    [Abstract] [Full Text] [Related]

  • 37. Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement.
    Lee KW, Yi J, Choi IS, Kim JH, Bang SM, Kim DW, Im SA, Kim TY, Yoon SS, Lee JS, Bang YJ, Park S, Kim BK, Cho HI, Heo DS.
    Ann Hematol; 2009 Sep 02; 88(9):829-38. PubMed ID: 19172274
    [Abstract] [Full Text] [Related]

  • 38. Prophylaxis strategies containing high dose intravenous methotrexate on preventing CNS relapse for patients with diffuse large B-cell lymphoma at intermediate to high risk: A study based on 12 cohorts in the rituximab era.
    Zhang N, Xu D, Liu B, Shi X, Xie X, Wang Z.
    Int Immunopharmacol; 2022 Dec 02; 113(Pt A):109299. PubMed ID: 36252471
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy.
    Al Feghali KA, Fang P, Gule-Monroe M, Milgrom S, Khoury JD, Gunther JR, Sheu T, Nair R, Ahmed S, Steiner R, Strati P, Shpall EJ, Nieto YL, Hosing C, Nastoupil LJ, Westin JR, Neelapu SS, Fowler N, Flowers C, Pinnix CC, Dabaja BS.
    Leuk Lymphoma; 2021 Oct 02; 62(10):2400-2407. PubMed ID: 33942701
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.